ArticleInflammatory intestinal diseases

Efficacy of Ustekinumab on Skin Reactions Induced by Tumor Necrosis Factor-Alpha Inhibitors in Patients with Inflammatory Bowel Disease.

Koji Fujimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.